Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

Ferring Highlights Commitment to C. Diff Infection Community on the Second Anniversary of the Launch of REBYOTA® (fecal ...

T he antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C.

In general, strive to use antibiotics covering a spectrum no broader than necessary and narrow the antibiotic spectrum of treatment after ... Mild Clostridium difficile infection (CDI; stool ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Against that backdrop, the shortlisting of Astellas Pharma's C. diff treatment Dificlir (fidaxomicin) for the UK Prix Galien Innovative Product Award, reflects the critical need for additional ...

Video content above is prompted by the following: What are the main unmet needs for recurrent C difficile infections and how do you see the field evolving in the future?

EP: 12.Common Comorbidities Associated With Recurrent C Difficile Infections ...

There are currently no C. difficile vaccines available, and the main treatment for the infection is a lengthy course of ...

difficile or C. diff, is a colon disease that can cause ... condition around the world and the resulting need for efficient treatment options. A rise in R&D efforts, with an emphasis on innovative ...

Once C-diff is in the ascendancy it can be very hard to shift – the traditional treatment is antibiotics but a significant number of patients do not respond and are left with relentless and ...